HKEX Stock Code: 01093English|繁體|简体

Highlight - 2025H1 Results

Revenue
RMB 13,273M, -18.5%
Reported profit attributable to shareholders of the Company
RMB2,548M, -15.6%
Underlying profit attributable to shareholders of the Company
RMB2,320M, -27.9%
Basic earnings per share (based on reported profit)
RMB22.29 cents, -12.6%
Basic earnings per share (based on underlying profit)
RMB20.29 cents, -25.3%

Key Products

Finished drugs
Bulk drugs
© Copyright 2025 CSPC Pharmaceutical Group Limited. All Rights Reserved.